UChicagoCancerCenter (@uccancercenter) 's Twitter Profile
UChicagoCancerCenter

@uccancercenter

A Comprehensive Cancer Center designated by @theNCI for 50+ yrs. #NothingWillStopUs #NCIDesignated #UChiCancer50 @UCMOCECHE uchicagocancer.bsky.social

ID: 150794946

linkhttps://www.uchicagomedicine.org/cancer calendar_today01-06-2010 21:14:15

14,14K Tweet

9,9K Followers

1,1K Following

Dr. Patrick Hwu (@patrickhwumd) 's Twitter Profile Photo

Hey #ASCO25, #TheCheckPoints are thrilled to have you on our dance floor tonight in Chicago! 💃 Thanks for showing up and making it a party. For those of you missing the gig BuddyGuysLegends, here’s our cover of Bruno Mars Uptown Funk! 🎶 Russell Pachynski Jason Luke, MD, FACP Rachel Humphrey

UChicagoCancerCenter (@uccancercenter) 's Twitter Profile Photo

At #ASCO25, Faith Abodunrin, MD (Faith Abodunrin MD) presented a poster showing promising findings on functional and survival outcomes in HPV-positive oropharyngeal cancer with response-adaptive radiation de-escalation strategy. UChicagoOHNS Ari Rosenberg University of Chicago Hematology/Oncology

UChicagoCancerCenter (@uccancercenter) 's Twitter Profile Photo

At #ASCO25, Jincong Freeman presented a poster that shows the differences in pathologic complete response to neoadjuvant chemotherapy in early-stage male breast cancer among different molecular subtypes and racial/ethnic groups. UChicago Public Health Sciences University of Chicago Hematology/Oncology UChicago Medicine

At #ASCO25, Jincong Freeman presented a poster that shows the differences in pathologic complete response to neoadjuvant chemotherapy in early-stage male breast cancer among different molecular subtypes and racial/ethnic groups. <a href="/UChicagoPHS/">UChicago Public Health Sciences</a> <a href="/UChicagoHemOnc/">University of Chicago Hematology/Oncology</a> <a href="/UChicagoMed/">UChicago Medicine</a>
UChicagoCancerCenter (@uccancercenter) 's Twitter Profile Photo

Austin Wesevich, MD, shares the data showing lower rate of international medical graduates (IMG) recruitment in oncology, highlighting that need to eliminate the barriers in IMG recruitment to address the growing oncology workforce shortage. #ASCO25 UChicago Medicine University of Chicago Hematology/Oncology

Austin Wesevich, MD, shares the data showing lower rate of international medical graduates (IMG) recruitment in oncology, highlighting that need to eliminate the barriers in IMG recruitment to address the growing oncology workforce shortage. #ASCO25
<a href="/UChicagoMed/">UChicago Medicine</a> <a href="/UChicagoHemOnc/">University of Chicago Hematology/Oncology</a>
The University of Chicago (@uchicago) 's Twitter Profile Photo

Meet the speaker: Prof. Kunle Odunsi, renowned oncologist and director of UChicago's UChicagoCancerCenter, will address graduates at the 2025 Convocation ceremony on June 7. Learn more: ms.spr.ly/6018SlrJG

Meet the speaker: Prof. Kunle Odunsi, renowned oncologist and director of UChicago's <a href="/UCCancerCenter/">UChicagoCancerCenter</a>, will address graduates at the 2025 Convocation ceremony on June 7.

Learn more: ms.spr.ly/6018SlrJG
UChicagoCancerCenter (@uccancercenter) 's Twitter Profile Photo

Leah Goldberg, MD, presents survey results on the current understanding and resources available to internal medicine residents to handle common H/O emergencies. #MedicalEducation Anand Patel University of Chicago Hematology/Oncology

Leah Goldberg, MD, presents survey results on the current understanding and resources available to internal medicine residents to handle common H/O emergencies. #MedicalEducation <a href="/Anand_88_Patel/">Anand Patel</a> <a href="/UChicagoHemOnc/">University of Chicago Hematology/Oncology</a>
UChicagoCancerCenter (@uccancercenter) 's Twitter Profile Photo

At #ASCO25, Michael Bishop, MD discussed the abstracts presented by Pierre Yves Dumas, MD, PhD and Arjun Datt Law, MD on advances in immuno- and cellular therapy in leukemia—highlighting improved long-term OS with PTCY and the role of γδ T cells as “nature’s CAR-T”.

At #ASCO25, Michael Bishop, MD discussed the abstracts presented by Pierre Yves Dumas, MD, PhD and Arjun Datt Law, MD on advances in immuno- and cellular therapy in leukemia—highlighting improved long-term OS with PTCY and the role of γδ T cells as “nature’s CAR-T”.
Journal of Experimental Medicine (@jexpmed) 's Twitter Profile Photo

Wen, Ralph Weichselbaum et al. review how YTHDF proteins regulate tumor responses to radiotherapy by modulating DNA repair & the immune microenvironment & discuss their potential as therapeutic targets to enhance the efficacy of radiotherapy & #immunotherapy hubs.la/Q03qTwbh0

Wen, <a href="/rweichselbaum/">Ralph Weichselbaum</a> et al. review how YTHDF proteins regulate tumor responses to radiotherapy by modulating DNA repair &amp; the immune microenvironment &amp; discuss their potential as therapeutic targets to enhance the efficacy of radiotherapy &amp; #immunotherapy  hubs.la/Q03qTwbh0
Society for Immunotherapy of Cancer (@sitcancer) 's Twitter Profile Photo

We are currently accepting abstract submissions for #SITC25. Submit your Regular or Young Investigator Award (YIA) Abstracts by June 26. All accepted abstracts are published in Journal for ImmunoTherapy of Cancer. Consider submitting your cutting-edge research today! sitcancer.org/2025/abstracts…

We are currently accepting abstract submissions for #SITC25. Submit your Regular or Young Investigator Award (YIA) Abstracts by June 26. All accepted abstracts are published in <a href="/jitcancer/">Journal for ImmunoTherapy of Cancer</a>. Consider submitting your cutting-edge research today! sitcancer.org/2025/abstracts…
UChicagoCancerCenter (@uccancercenter) 's Twitter Profile Photo

In a recent study, Stephen Kron, PhD, and colleagues at Northwestern demonstrates that the novel chemical probe NU-PRO-1 effectively degrades TERT, delays DNA repair, and sensitizes cancer cells to radiation. Karl Scheidt Ludwig Cancer Lurie Cancer Center ow.ly/Plho50W6ruP

In a recent study, Stephen Kron, PhD, and colleagues at <a href="/NorthwesternU/">Northwestern</a> demonstrates that the novel chemical probe NU-PRO-1 effectively degrades TERT, delays DNA repair, and sensitizes cancer cells to radiation. <a href="/karl_scheidt/">Karl Scheidt</a> <a href="/Ludwig_Cancer/">Ludwig Cancer</a> <a href="/LurieCancer/">Lurie Cancer Center</a>
ow.ly/Plho50W6ruP
UChicago Medicine (@uchicagomed) 's Twitter Profile Photo

Immunotherapy is revolutionizing cancer care, but the journey is far from over. Learn how our experts are finding new ways to harness the body’s ability to fight off the disease. biologicalsciences.uchicago.edu/news/whats-nex…

Immunotherapy is revolutionizing cancer care, but the journey is far from over. Learn how our experts are finding new ways to harness the body’s ability to fight off the disease. biologicalsciences.uchicago.edu/news/whats-nex…
University of Chicago Hematology/Oncology (@uchicagohemonc) 's Twitter Profile Photo

Clinical Research Coordinators are the backbone of our clinical trials work! Learn more about the impact they make in part 1 of our "Day in the Life of a CRC" video series!! #ClinicalTrials #ClinicalTrialsAwareness #ClinicalResearchCoordinator UChicagoCancerCenter UChicago Medicine

University of Chicago Hematology/Oncology (@uchicagohemonc) 's Twitter Profile Photo

Drs. Noura Choudhury, MD & Marina Garassino have a great new paper out in The Lancet about the importance of the maintenance phase of treatment in extensive-stage small-cell lung cancer! You can read it at thelancet.com/journals/lance… #lungcancer #lungcancertreatment

UChicagoCancerCenter (@uccancercenter) 's Twitter Profile Photo

Researchers in our Cancer Prevention and Control program promote novel cancer population science discoveries through interdisciplinary research and translate this knowledge into clinical and public health practice to reduce risk and increase survivorship. ow.ly/QNP850Wa7tZ

UChicagoCancerCenter (@uccancercenter) 's Twitter Profile Photo

🌟 We’re thrilled to spotlight Brandon Pierce as a leader of our Cancer Prevention and Control program. His lab investigates how genetics influence the effects of environmental exposures and biomarkers on health and disease. UChicago Public Health Sciences Brandon Pierce ow.ly/rZGF50Wa8hu

🌟 We’re thrilled to spotlight Brandon Pierce as a leader of our Cancer Prevention and Control program. His lab investigates how genetics influence the effects of environmental exposures and biomarkers on health and disease. <a href="/UChicagoPHS/">UChicago Public Health Sciences</a> <a href="/BrandonL_Pierce/">Brandon Pierce</a>
ow.ly/rZGF50Wa8hu
UChicagoCancerCenter (@uccancercenter) 's Twitter Profile Photo

🌟 Meet Loren Saulsberry, assistant leader of the Cancer Prevention and Control program. A health policy expert, she studies how policy and health communication shape cancer care and outcomes—especially for underrepresented communities. UChicago Public Health Sciences pbhs.uchicago.edu/faculty/loren-…

🌟 Meet Loren Saulsberry, assistant leader of the Cancer Prevention and Control program. A health policy expert, she studies how policy and health communication shape cancer care and outcomes—especially for underrepresented communities. <a href="/UChicagoPHS/">UChicago Public Health Sciences</a> 
pbhs.uchicago.edu/faculty/loren-…